EMA — authorised 24 May 2018
- Marketing authorisation holder: Ammtek
- Status: approved
EMA authorised Micronase on 24 May 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 24 May 2018.
Ammtek holds the EU marketing authorisation.